Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Classifica tra le azioni #33269
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Prezzo delle azioni
$5.47
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$7.99M
Variazione (1 giorno)
6.21%
Variazione (1 anno)
7.47%
Paese
US
Scambia CNS Pharmaceuticals, Inc. (CNSP)

Categoria

Il prezzo CNSP con la capitalizzazione del mercato della B
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
CNSP
$5.47
Capitalizzazione di mercato di CNS Pharmaceuticals, Inc.(CNSP)
Capitalizzazione di mercato: $7.99M
A partire dal August 2026, CNS Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $7.99M. Questo rende CNS Pharmaceuticals, Inc. la 33269th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di CNS Pharmaceuticals, Inc. dal 2019 al 2026
CNSP in paragone con la classifica dei più popolari stocks
Il prezzo per CNSP Attivo B Capitalizzazione del mercato a B Risultati
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,730,311 $7.99M
$5.452T +68,195,709.39%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,072,189 $7.99M
$4.490T +56,164,241.21%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,848,028 $7.99M
$4.162T +52,066,224.70%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,515,450 $7.99M
$3.676T +45,986,185.89%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$1,938,442 $7.99M
$2.833T +35,437,596.65%